Aarti Drugs stocks: Buy Aarti Drugs, target price Rs 570: Axis Securities
Aarti Drugs Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 4376.11 Crore) operating in Pharmaceuticals sector.
Aarti Drugs Ltd. key Products/Revenue Segments include Pharmaceuticals for the year ending 31-Mar-2023. Financials
For the quarter ended 31-03-2024, the company reported a Consolidated Total Income of Rs 621.07 Crore, up 2.22 % from last quarter Total Income of Rs 607.61 Crore and down -16.44 % from last year same quarter Total Income of Rs 743.28 Crore. Company reported net profit after tax of Rs 47.31 Crore in latest quarter. Promoter/FII Holdings
Promoters held 57.13 per cent stake in the company as of 31-Mar-2024, while FIIs owned 2.56 per cent, DIIs 5.99 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
For gold bulls, sky is the limit, but a hurdle lurks and could trigger profit booking. Here’s why
overbought zone: IT largecap stocks not in overbought zone after Friday’s rally: Anand James
Sebi gives relaxation in timeline for reporting differential rights issues by AIFs
About The Author
